Tag: FDA Advisory Committees Joint Meeting December 2011
-
Ortho Evra Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Deep Vein Thrombosis & Pulmonary Embolism
Given These New FDA Drug Safety Findings About Ortho Evra, What Will Two Advisory Committees Do At Joint Meeting On December 9, 2011? (Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA…
-
YAZ / Yasmin / Ocella Update: October 2011 FDA Study Finds Increased Risk Of Blood Clot Side Effects Like DVT, PE, Stroke, And Heart Attack
Safety Study Findings About Drospirenone (DRSP) Birth Control Pills Will Be On The Agenda For FDA Advisory Committees At Joint Meeting In December 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On October 27, 2011 the FDA…
-
NuvaRing Update: October 2011 FDA Study Finds Increased Risk Of Pulmonary Embolism (PE) And Deep Vein Thrombosis (DVT)
Will NuvaRing Safety Study Findings Be Addressed By FDA Advisory Committees At Joint Meeting In December 2011? (Posted by Tom Lamb at DrugInjuryWatch.com) ______________________________________________________________________________ UPDATE: "October 2013 NuvaRing Label Change: Warnings And Precautions Section…